Placeholder Banner

BIO-Europe Spring Opening Remarks

March 12, 2013
BIO's own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring conference in Barcelona yesterday. His slides provide a snapshot of the biotech industry's performance and highlight emerging trends in venture exits: IPOs and M&A.

Takeaways from his talk include breakouts on multiple fronts for the industry:

  • FDA approvals at highs not seen since the 1990s

  • Orphan designation approvals at all-time highs

  • IPOs starting to show signs of life in 2012 and 2013

  • Highest level of structured acquisitions in 2012

  • Highest number of corporate venture rounds on record for 2012

  • Venture returns trending up in 2012

Download the full slide deck here: BES13 - David Thomas Slides